Oppenheimer Reiterates Outperform Rating On Stericycle

According to Oppenheimer, Stericycle SRCL saw a solid in-line quarter. Oppenheimer said that 2Q11 adj'd EPS of $0.69 (+13% y/y, reported EPS was $0.63 on 1x items) was in line with the estimate/consensus. “We reiterate our Outperform rating and $100 price target given SRCL's steadiness.” Stericycle closed yesterday at $89.46.